Postmenopausal hormone therapy and atherosclerotic disease

American Heart Journal

Volumn 128, Issue 6 PART 2, 1994, Pages 1337-1343

  Manson, JoAnn E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; HORMONE; LEVONORGESTREL;

ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSDERMAL DRUG ADMINISTRATION;

AGED; ANIMAL; ARTERIOSCLEROSIS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; MIDDLE AGE; RISK ASSESSMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028019216     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(94)90257-7     Document Type: Article

References (61)

1. Coronary heart disease and its risk factors among women in the Framingham Study
2. Menopause and heart disease: a review
3. Estrogen replacement therapy and coronary heart disease: a quantitiative assessment of the epidemiologic evidence
4. Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
5. Effects of pharmacologic agents used, during menopause: impact on lipids and lipoproteins
6. Effects of conjugated equine estrogen with an without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-1
7. Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function
8. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins
9. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies
10. The primary prevention of myocardial infarction
11. A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids
12. Comparison of sequential versus continuous estrogen/progestin replacement therapy on serum lipid patterns: Multiuniversity National Upjohn Study Collaborative
13. Lipid metabolic studies in oophorectomized women: effects on serum lipids and lipoproteins of three synthetic progestogens
14. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice
15. The Effects of Reproductive Hormones on Serum Lipoproteins: Unresolved Issues in Biology and Clinical Practicea
16. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
17. Postmenopausal Estrogen Use and Heart Disease Risk Factors in the 1980s
18. The effects of conjugated equine oestrogens with and without a cyclical progestin on lipoproteins and HDL subfractions in postmenopausal women
19. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient
20. Post-menopausal hormone replacement therapy—effects of progestogens on serum lipids and lipoproteins: a review
21. Effects of progestins on plasma lipoproteins and heparin-releasable lipases
22. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women
23. Lipoprotein (a): an emerging risk factor for atherosclerosis
24. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study
25. Postmenopausal use of estrogen and occlusion of coronary arteries
26. Sex steroid hormone receptors in the cardiovascular system
27. Oestrogens, arterial status, and postmenopausal women
28. The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow
29. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
30. Cardiovascular protection by estrogen—a calcium antagonist effect?
31. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins
32. Clotting factors and ischaemic heart disease: the epidemiologic evidence
33. Ischemic heart disease risk in postmenopausal women: effects of estrogen use on glucose and insulin levels
34. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus
35. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
36. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits
37. Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug Project
38. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone
39. Estrogen modulates responses of atherosclerotic coronary arteries
40. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle
41. Postmenopausal estrogen use and coronary atherosclerosis
42. Risk factors and noncontraceptive estrogen use in women with and without coronary disease
43. Wplyw leczenia estrogenami na niewydolnose wiencowa u kobiet po menopauzie
44. Effects of long-term estrogen replacement therapy, I: metabolic effects
45. Estrogen replacement therapy, II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
46. Postmenopausal estrogen replacement: the prevention of osteoporosis and systemic effects
47. A prospective study of postmenopausal estrogen therapy and coronary heart disease
48. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study
49. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study
50. Postmenopausal estrogen use and mortality
51. Estrogen replacement therapy and protection from acute myocardial infarction
52. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study
53. Use of replacement estrogens and the risk of myocardial infarction
54. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women
55. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study
56. Noncontraceptive estrogen use and risk of cardiovascular disease: an overview and critique of the literature
57. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis
58. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women
59. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement
60. Uncertainty about postmenopausal estrogen: time for action, not debate
61. Postmenopausal estrogen and prevention bias